Epiminder
Company · Melbourne, Australia
Developing Minder, an implant under the scalp that records EEG continuously for long-term epilepsy monitoring.
In the news
ImplantsRegulation
FDA clears Epiminder's implanted EEG monitor for adolescents with drug-resistant epilepsy
The expanded clearance lowers the Minder system's minimum age from 18 to 12, giving teenagers access to continuous EEG recorded outside the hospital.
Clinical trialsImplants
Epiminder enrolls 100 people in its US trial of implanted long-term EEG monitoring for epilepsy
The randomized DETECT study is testing whether the under-the-scalp Minder system improves care decisions for people with drug-resistant epilepsy.